Clinical implementation of gene-silencing technologies has reached a definitive milestone as of January 2026, with the European Medicines Agency granting accelerated pathways for lipid-nanoparticle-delivered RNAi treatments. These precision interventions, specifically targeting the production of transthyretin proteins, are fundamentally altering the management of restrictive cardiomyopathies....

Market Overview The global breast implants market size was valued at USD 1.99 billion in 2024 and is expected to grow from USD 2.17 billion in 2025 to USD 3.91 billion by 2033, growing at a CAGR of 7.42% during the forecast period (2025-2033). The global Breast Implants market continues to evolve rapidly, driven by shifting consumer trends, rising...